CN1559529A - Medicine for treating urticaria - Google Patents

Medicine for treating urticaria Download PDF

Info

Publication number
CN1559529A
CN1559529A CNA2004100142494A CN200410014249A CN1559529A CN 1559529 A CN1559529 A CN 1559529A CN A2004100142494 A CNA2004100142494 A CN A2004100142494A CN 200410014249 A CN200410014249 A CN 200410014249A CN 1559529 A CN1559529 A CN 1559529A
Authority
CN
China
Prior art keywords
radix
urticaria
grams
perhaps make
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CNA2004100142494A
Other languages
Chinese (zh)
Other versions
CN1242781C (en
Inventor
郭士全
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB2004100142494A priority Critical patent/CN1242781C/en
Publication of CN1559529A publication Critical patent/CN1559529A/en
Application granted granted Critical
Publication of CN1242781C publication Critical patent/CN1242781C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

A Chinese medicine for treating urticaria is prepared from 15 Chinese-medicinal materials including schizonepeta, ledebouriella root, Chinese angelica root, liquorice root, etc.

Description

The urticarial medicine of a kind of treatment
Technical field
The invention relates to the urticarial Chinese medicine of treatment, is that a kind of pure compound Chinese medicinal preparation is treated urticarial medicine.
Background technology
Urticaria is commonly called as " wind pimple ", and " urticaria " is a kind of common anaphylactic disease.The doctor trained in Western medicine antiallergic agent can only be removed sensitizers such as histamine, eliminates allergic symptom, takes stopgap measures and does not effect a permanent cure, in case contact sensitinogen again, then can recur, and is if delay into chronic urticaria, then obstinate difficult.The treatment by Chinese herbs urticaria can be eliminated the irritated mechanism of body, and treating both the principal and secondary aspects of a disease eradicate urticaria and be difficult for recurrence, but except that the graduate urticaria ball of the traditional Chinese medical science, it is still rare specially to control urticarial Chinese patent medicine.Thereby having a curative effect height, relapse rate is low specially controls the urgent needs that urticarial Chinese patent medicine is present urticaria market.
Summary of the invention
Purpose of the present invention just provides a kind of elimination urticaria, short treating period, the urticarial medicine of the treatment that relapse rate is low, at urticaria sickness rate height, harm is big, Western medicine is cured the symptoms, not the disease, and the drawback that Chinese patent medicine is rare not only obviously improves curative effect, patient's misery can be more effectively removed, and patient's medical treatment cost can be reduced.
The scheme that solves its technical problem is: Herba Schizonepetae 1-14%, Radix Saposhnikoviae 1-14%, Gypsum Fibrosum 2-24%, Radix Rehmanniae 2-24%, Spica Prunellae 2-24%, Radix Scrophulariae 2-24%, Rhizoma Atractylodis 2-24%, Radix Sophorae Flavescentis 2-24%, Rhizoma Anemarrhenae 1-14%, Periostracum Cicadae 1-14%, Radix Angelicae Sinensis 1-14%, Fructus Arctii 1-14%, Caulis Akebiae 1-14%, Radix Arnebiae (Radix Lithospermi) 1-14% and Radix Glycyrrhizae 0.4-6%.
Above-mentioned Chinese medicine is mixed the back decocting, and grate goes out medicinal liquid and makes decoction; Perhaps make mixture, earlier as the decoction decocting taking liquid, add 95% ethanol, be made into 75% suspension, left standstill 24 hours, decontamination is purified, simmer down to 30ml, and autoclaving, it is anticorrosion to add sodium benzoate 0.3g, the sealing fill; Perhaps make electuary, after purifying as mixture earlier, evaporation is anhydrated, and the foam of getting it filled adds substrate system granule; Perhaps make tablet, after foam is got it filled in evaporation as electuary, add the substrate tabletting, pack after the sterilization; Perhaps make capsule, capsule conventional formulation method is made capsule.
Beneficial effect: adopt such scheme,, on the basis of knowing the urticaria etiology and pathogenesis clearly, utilize the Therapeutic Method of Chinese medical discrimination opinion, prepare the urticarial effective pure Chinese medicine medicine of a kind of treatment meticulously through big quantity research and clinical practice.Its major advantage is thoroughly to have known urticarial pathogenesis clearly, the dialectical key of having hited, so the curative effect height, short treating period is difficult for recurrence.Clinical verification, total effective rate reaches 93.64%.The course of treatment: acute measles 3-6 days, chronic urticaria 20-30 days.
Not only can satisfy the urticarial urgent needs of sociotherapy, and urticaria is reached radical cure not recur, and not need the fasting fish sensitization food such as to frighten more, can not only significantly improve clinical efficacy, and can make patient reduce medical treatment cost, reduce medical expense.So have vast market prospect, if can develop, will obtain good economic benefit and social benefit.
The specific embodiment
Embodiment 1: the treatment urticaria drug: Herba Schizonepetae 10 grams, Radix Saposhnikoviae 10 grams, Gypsum Fibrosum 30 grams, the Radix Rehmanniae 30 grams, Spica Prunellae 30 grams, Radix Scrophulariae 30 grams, Rhizoma Atractylodis 30 grams, Radix Sophorae Flavescentis 30 grams, the Rhizoma Anemarrhenae 10 grams, Periostracum Cicadae 10 grams, Radix Angelicae Sinensis 12 grams, Fructus Arctii 10 grams, Caulis Akebiae 6 grams, Radix Arnebiae (Radix Lithospermi) 12 grams, Radix Glycyrrhizae 6 grams.Be daily dose;
Make decoction, be decocted in water for oral dose, 1 dose of day, divide clothes 2 times.Anxious collection urticaria 3-6 agent was 1 course of treatment, and chronic urticaria 20-40 agent was 1 course of treatment.
Clinical effectiveness is observed: urticaria is clinical common refractory disease, utilizes urticaria soup treatment urticaria 110 examples, and matched group 60 examples, is reported as follows.
1. clinical data
Selection meets Wu Zhihua chief editor " skin cypridology " [1]Urticaria patient's 170 examples of relevant urticaria diagnostic criteria are divided into two groups, and 110 examples are organized in treatment, male 49 examples, and women 61 examples, in age 6-72 year, average 33.2 ± 11.3 years old, the course of disease was the shortest 3 days, and is the longest 16 years, average 283.7 ± 16.7 days.Acute 78 examples, 32 examples.Matched group 60 examples, in age 7-56 year, average 28.7 ± 8.4 years old, the course of disease was the shortest 3 days, and is the longest 20 years, average 207.5 ± 17.9 days.Acute 42 examples, chronic 18 examples.
2. Therapeutic Method decoction: be decocted in water for oral dose, day 1 dose, divide clothes 2 times.
Treatment group urticaria soup: Herba Schizonepetae 10 grams, Radix Saposhnikoviae 10 grams, Gypsum Fibrosum 30 grams, the Radix Rehmanniae 30 grams, Spica Prunellae 30 grams, Radix Scrophulariae 30 grams, Rhizoma Atractylodis 30 grams, Radix Sophorae Flavescentis 30 grams, the Rhizoma Anemarrhenae 10 grams, Periostracum Cicadae 10 grams, Radix Angelicae Sinensis 12 grams, Fructus Arctii 10 grams, Caulis Akebiae 6 grams, Radix Arnebiae (Radix Lithospermi) 12 grams, Radix Glycyrrhizae 6 grams.Be daily dose; 1 dose of day, divide clothes 2 times.3-6 days observe the curative effect of acute urticaria clothes.1 month observe the curative effect of chronic urticaria clothes.
Matched group hismanal 10mg/ time, 1 time/day, plug pyridine in heptan 2mg/ time, 2 times/day.3-6 days observe the curative effect of acute urticaria clothes.1 month observe the curative effect of chronic urticaria clothes.
Two groups are all finished later six months and 1 year the course of treatment and respectively follow up a case by regular visits to 1 time.
Table 1. liang group curative effect is (example) relatively
Cure enabledisable total effective rate (%) x 2P
Treatment organizes acute 59 18 1 98.72 16.15<0.005
Chronic 18 86 81. 25 3.25>0.05
Add up to 77 26 7 93.64 19.15<0.005
Matched group acute 13 18 11 73.81
Chronic 468 55.56
Add up to 7 24 19 68.33
3. criterion of therapeutical effect and therapeutic outcome
Criterion of therapeutical effect is with reference to factitial urticaria such as Li Yuanwen treatment standard.Cure: erythra disappears fully, and pruritus disappears, and follows up a case by regular visits to 1 year person of not sending out.Effectively: deflorescence, pruritus disappear, and 1 is only and sends out 1 time, and the clothes top is the responder still.Invalid: erythra has to disappear or do not have and disappears, and pruritus alleviates or do not have and alleviates, recurrence person more than 2 times in 1 year.Two groups of curative effects such as tables 1.By table 1 as seen, treatment group curative effect obviously is better than matched group (P<0.005), and especially the effect of acute urticaria is good (P<0.005) than matched group.
Urticaria belongs to sick category such as the traditional Chinese medical science " rubella ", " eczema " " angioneurotic edema ", and the pathogenesis that gets to the bottom of sb.'s illness is mainly due to innate deficiency, the heresy that affection of exogenous wind-cold is damp and hot, cohesion flesh table, or improper diet, the product that the surfeit smelling of fish or mutton is pungent, help humidogene heat, lead to pyretic toxicity, interior must not be saturating, must not send out outward, cause stagnation of QI-blood, generate rubella wheal.Manyly in the past controlled from the wind heat opinion, many with dispersing the product of letting out clearly, and ignore the damp eliminating blood stasis dispelling, thus can not speed heal, and be easy to recur.Because of though wind benefaction number becomes, be easy to speed and dispel, in a single day right fighting with wetting phase, then touching difficulty more is difficult for eradicating.Damp is kind again checks mechanism of qi, and the heat of skin can not be sent out thoroughly, and stagnation of QI-blood is difficult for speed more.Event must dispersed on the basis of wind heat, holds concurrently with damp eliminating, and cooling blood and removing stasis, the stasis of blood is logical can speed to heal, and wets and dispels and can eradicate.So the present invention uses Herba Schizonepetae, Radix Saposhnikoviae, Periostracum Cicadae, Fructus Arctii earlier, dispelling exopathogens from superficies of the body, make pathogenic heat send out thoroughly in outside, Gypsum Fibrosum, the Rhizoma Anemarrhenae, clearing away heat-fire is with strongly fragrant pyretic toxicity in rushing down.Add Spica Prunellae, Rhizoma Atractylodis, Radix Sophorae Flavescentis, Caulis Akebiae again on this basis, heat clearing and damp drying, the Radix Rehmanniae, Radix Scrophulariae, Radix Arnebiae (Radix Lithospermi), Radix Angelicae Sinensis, the cooling blood and removing stasis rash, double getting controlled the meaning that wind is controlled blood earlier.All medicines share, and interior-heat is clear, and exterior heat is loose, and wet blood stasis dispelling is logical, and measles toxin is passed through inside, so the merit of receiving.
Embodiment 2: the prescription with embodiment 1 is made mixture, earlier as the decoction decocting taking liquid, adds 95% ethanol, is made into 75% suspension, leaves standstill 24 hours, and decontamination is purified, simmer down to 30ml, and autoclaving, it is anticorrosion to add sodium benzoate 0.3g, the sealing fill.3 times/day, 10ml/ time, other and embodiment 1 omit together.
Embodiment 3: the prescription with embodiment 1 is made electuary, and after purifying as mixture earlier, evaporation is anhydrated, and the foam of getting it filled adds substrate system granule, makes 3 bags, and 3 times/day, 1 bag/time; Other and embodiment 1 omit together.
Embodiment 4: the prescription with embodiment 1 is made tablet, after foam is got it filled in evaporation as electuary, adds the substrate tabletting, makes 12 altogether, pack after the sterilization, and 3 times/day, the 2-4 sheet/time.Other and embodiment 1 omit together.
Embodiment 5: the prescription with embodiment 1 is made capsule, and capsule conventional formulation method is made capsule, divides clothes every day 3 times, and other and embodiment 1 omit together.

Claims (1)

1, the urticarial medicine of a kind of treatment is characterized in that: Herba Schizonepetae 1-14%, Radix Saposhnikoviae 1-14%, Gypsum Fibrosum 2-24%, Radix Rehmanniae 2-24%, Spica Prunellae 2-24%, Radix Scrophulariae 2-24%, Rhizoma Atractylodis 2-24%, Radix Sophorae Flavescentis 2-24%, Rhizoma Anemarrhenae 1-14%, Periostracum Cicadae 1-14%, Radix Angelicae Sinensis 1-14%, Fructus Arctii 1-14%, Caulis Akebiae 1-14%, Radix Arnebiae (Radix Lithospermi) 1-14% and Radix Glycyrrhizae 0.4-6%;
Above-mentioned Chinese medicine is mixed the back decocting, and grate goes out medicinal liquid and makes decoction; Perhaps make mixture, earlier as the decoction decocting taking liquid, add 95% ethanol, be made into 75% suspension, left standstill 24 hours, decontamination is purified, simmer down to 30ml, and autoclaving, it is anticorrosion to add sodium benzoate 0.3 g, the sealing fill; Perhaps make electuary, after purifying as mixture earlier, evaporation is anhydrated, and the foam of getting it filled adds substrate system granule; Perhaps make tablet, after foam is got it filled in evaporation as electuary, add the substrate tabletting, pack after the sterilization; Perhaps make capsule, capsule conventional formulation method is made capsule.
CNB2004100142494A 2004-03-06 2004-03-06 Medicine for treating urticaria Expired - Fee Related CN1242781C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2004100142494A CN1242781C (en) 2004-03-06 2004-03-06 Medicine for treating urticaria

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2004100142494A CN1242781C (en) 2004-03-06 2004-03-06 Medicine for treating urticaria

Publications (2)

Publication Number Publication Date
CN1559529A true CN1559529A (en) 2005-01-05
CN1242781C CN1242781C (en) 2006-02-22

Family

ID=34440279

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2004100142494A Expired - Fee Related CN1242781C (en) 2004-03-06 2004-03-06 Medicine for treating urticaria

Country Status (1)

Country Link
CN (1) CN1242781C (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101810799A (en) * 2010-05-26 2010-08-25 泰一和浦(北京)中医药研究院有限公司 Chinese medicinal composition for treating eruption and preparation method thereof
CN101579470B (en) * 2009-06-10 2011-03-30 平阴县中医医院 Oral medicine for treating dermatosis and preparation method thereof
CN104491514A (en) * 2014-12-07 2015-04-08 唐云峰 Traditional Chinese medicine composition for treating blood-heat type urticaria

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101579470B (en) * 2009-06-10 2011-03-30 平阴县中医医院 Oral medicine for treating dermatosis and preparation method thereof
CN101810799A (en) * 2010-05-26 2010-08-25 泰一和浦(北京)中医药研究院有限公司 Chinese medicinal composition for treating eruption and preparation method thereof
CN104491514A (en) * 2014-12-07 2015-04-08 唐云峰 Traditional Chinese medicine composition for treating blood-heat type urticaria

Also Published As

Publication number Publication date
CN1242781C (en) 2006-02-22

Similar Documents

Publication Publication Date Title
CN103272169B (en) Application of rhodiola rosea compound composite in treating erosive gastritis
CN103285309B (en) Rhodiola rosea compound composition for treating peptic ulcer
CN103386022A (en) Chinese medicine composition for treating tuberculous pleurisy
CN102949619B (en) Traditional Chinese medicine composition for treating colitis
CN101856481A (en) Externally used ointment for dispersing swelling and dissipating binds
CN101129923A (en) Traditional Chinese medicine preparation for treating endometritis
CN1330355C (en) Chinese medicinal composition for treating ulcer
CN102861160B (en) Traditional Chinese medicine hemorrhoid elimination decotion
CN1242781C (en) Medicine for treating urticaria
CN101129627A (en) Traditional Chinese medicine formulated product for treating post partum toxin fever
CN101530516B (en) Chinese medicament for treating appendicitis
CN1314427C (en) Medicine for treating menalgia
CN100411672C (en) A medicinal composition for treatment of psoriasis
CN105287949A (en) Traditional Chinese medicinal composition for treating dysmenorrhea
CN100367997C (en) Medicine for treating arthrolithiasis and preparing method thereof
CN100488526C (en) Oral preparation
CN1943766A (en) A Chinese traditional medicinal preparation for treatment of psoriasis
CN104288597A (en) Traditional Chinese medicine composition for treating herpes zoster
CN103721058A (en) Traditional Chinese medicine preparation for preventing influenza viruses
CN103520638B (en) A kind of Traditional Chinese medicine compound composition for the treatment of prostate hyperplasia and preparation method thereof and application thereof
CN101961481A (en) Traditional Chinese medicine for treating liver-gallbladder qi stagnation type cholecystitis and preparation method thereof
CN102366574A (en) Externally applied Chinese herbal powder for treating beriberi
CN107335011A (en) Treat the external application Chinese medicine compound preparation of cancer pain
CN101569681A (en) Traditional Chinese medicine for treating urinary infection
CN101129724A (en) Traditional Chinese medicine formulated product for treating salpingitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee